Dead Genes Puzzling

Reprinted with permission from Nature LEPROSY REDUCED: Circular genome map showing the position and orientation of known genes, pseudogenes and repetitive sequences. The scale in Mb is indicated by the numbers on the outside ring. Leprosy remains an epidemiological mystery, even 130 years after the leprosy bacillus was discovered.1 Despite the many helpful antibiotics now available to treat this mutilating disease, leprosy's transmission and mechanism of cell and tissue destruction remain

Written byEugene Russo
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Leprosy remains an epidemiological mystery, even 130 years after the leprosy bacillus was discovered.1 Despite the many helpful antibiotics now available to treat this mutilating disease, leprosy's transmission and mechanism of cell and tissue destruction remain poorly understood: Some 650,000 new cases are diagnosed worldwide each year, with about half in India and Brazil alone. But researchers are gaining a better understanding of the leprosy bacillus with the help of genomic data and insights provided by another infamous bacterial killer.

As part of a collaborative effort between L'Institut Pasteur in Paris and the Wellcome Trust Sanger Institute in Cambridge, UK, investigators highlighted intriguing genomic features of Mycobacterium leprae, the topic of this Hot Paper.2 The researchers compared M. leprae, the rod-shaped bacillus that causes leprosy, to its close relative, Mycobacterium tuberculosis, the bacillus that causes tuberculosis (TB). "Having two genome sequences is an extremely powerful way of understanding what happens ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies